To further confirm the correlation between CXCL10 expression and the immune microenvironment, the proportion of tumor-infiltrating immune subsets was analyzed using the CIBERSORT algorithm, and 21 kinds of immune cell profiles in PAAD patients were assessed (Fig. 8A). The gene discussed is CXCL10; the disease is pancreatic adenocarcinoma.